EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Aptamer-Hytac Chimeras for Targeted Degradation of SARS-CoV-2 Spike-1

Carme Fàbrega iD, Núria Gallisà-Suñé iD, Alice Zuin, Juan Sebastián Ruíz, Bernat Coll-Martínez iD, Gemma Fabriàs iD, Ramon Eritja iD, Bernat Crosas iD

Cells · 2024

DOI: 10.3390/cells13211767 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, 2024. Verfasst von Carme Fàbrega und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surfactants and Nanobiotechnology, Institute for Advanced Chemistry of Catalonia (IQAC-CSIC), Jordi Girona 18, 08034 Barcelona, Spain. Hauptthemen laut MEDLINE: Spike Glycoprotein, Coronavirus, Aptamers, Nucleotide, SARS-CoV-2, COVID-19. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CDTI (Center for Development and Technological Innovation), Ministry of Science, Ministry of Science, CIBER - Consorcio Centro de Investigación Biomédica en Red, Instituto de Salud Carlos III, and the European Regional Development Fund (ERDF).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The development of novel tools to tackle viral processes has become a central focus in global health, during the COVID-19 pandemic. The spike protein is currently one of the main SARS-CoV-2 targets, owing to its key roles in infectivity and virion formation. In this context, exploring innovative strategies to block the activity of essential factors of SARS-CoV-2, such as spike proteins, will strengthen the capacity to respond to current and future threats. In the present work, we developed and tested novel bispecific molecules that encompass: (i) oligonucleotide aptamers S901 and S702, which bind to the spike protein through its S1 domain, and (ii) hydrophobic tags, such as adamantane and tert-butyl-carbamate-based ligands. Hydrophobic tags have the capacity to trigger the degradation of targets recruited in the context of a proteolytic chimera by activating quality control pathways. We observed that S901-adamantyl conjugates promote the degradation of the S1 spike domain, stably expressed in human cells by genomic insertion. These results highlight the suitability of aptamers as target-recognition molecules and the robustness of protein quality control pathways triggered by hydrophobic signals, and place aptamer-Hytacs as promising tools for counteracting coronavirus progression in human cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Spike Glycoprotein, CoronavirusAptamers, NucleotideSARS-CoV-2COVID-19HumansProteolysisAdamantaneHEK293 CellsHydrophobic and Hydrophilic InteractionsProtein Binding

Stichwörter der Autor:innen

SARS-CoV-2adamantylaptamercoronavirusoligonucleotidespike proteintargeted protein degradationtert-butyl carbamate (Boc)

Substanzen

Spike Glycoprotein, CoronavirusAptamers, Nucleotidespike protein, SARS-CoV-2Adamantane

Autor:innen und Institutionen

  • Department of Surfactants and Nanobiotechnology, Institute for Advanced Chemistry of Catalonia (IQAC-CSIC), Jordi Girona 18, 08034 Barcelona, Spain.
  • Centro de Investigación Biomédica en Red de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), 28029 Madrid, Spain.
  • Proteasome Regulation Lab, Department of Cells and Tissues, Molecular Biology Institute of Barcelona (IBMB-CSIC), Baldiri i Reixac 4, 08028 Barcelona, Spain.
  • Lincbiotech SL, Avenida do Mestre Mateo, 2, 15706 Santiago de Compostela, Spain.
  • Department of Biological Chemistry, Institute for Advanced Chemistry of Catalonia (IQAC-CSIC), Jordi Girona 18, 08034 Barcelona, Spain.

ORCID-Profile: Carme Fàbrega, Núria Gallisà-Suñé, Bernat Coll-Martínez, Gemma Fabriàs, Ramon Eritja, Bernat Crosas

Förderung

  • CDTI (Center for Development and Technological Innovation), Ministry of Science
  • Ministry of Science
  • CIBER - Consorcio Centro de Investigación Biomédica en Red, Instituto de Salud Carlos III, and the European Regional Development Fund (ERDF)
  • CIBER—Consorcio Centro de Investigación Biomédica en Red
  • Instituto de Salud Carlos III
  • European Regional Development Fund (ERDF)
  • European Commission–NextGenerationEU

Zitieren

APA

Fàbrega, C., Gallisà-Suñé, N., Zuin, A., Ruíz, J. S., Coll-Martínez, B., Fabriàs, G., Eritja, R., & Crosas, B. (2024). Aptamer-Hytac Chimeras for Targeted Degradation of SARS-CoV-2 Spike-1. Cells. https://doi.org/10.3390/cells13211767

Vancouver

Fàbrega C, Gallisà-Suñé N, Zuin A, Ruíz JS, Coll-Martínez B, Fabriàs G, et al. Aptamer-Hytac Chimeras for Targeted Degradation of SARS-CoV-2 Spike-1. Cells. 2024. doi:10.3390/cells13211767

BibTeX
@article{Fbrega2024,
  author = {Fàbrega, Carme and Gallisà-Suñé, Núria and Zuin, Alice and Ruíz, Juan Sebastián and Coll-Martínez, Bernat and Fabriàs, Gemma and Eritja, Ramon and Crosas, Bernat},
  title = {Aptamer-Hytac Chimeras for Targeted Degradation of SARS-CoV-2 Spike-1},
  journal = {Cells},
  year = {2024},
  doi = {10.3390/cells13211767}
}
Kostenlos starten →